Milestone Scientific Research and Development Expenses 2010-2023 | MLSS

Milestone Scientific research and development expenses from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Milestone Scientific Annual Research and Development Expenses
(Millions of US $)
2023 $1
2022 $1
2021 $1
2020 $0
2019 $0
2018 $0
2017 $0
2016 $1
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Milestone Scientific Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $1
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $-0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.051B $0.010B
Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling the practitioner to more quickly and effectively anesthetize patients in certain dental applications. The company also markets and sells: ``SplatrFree(TM)`` disposable prophy angles and related consumable products; and clinically oriented dental products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.780B 20.42
Becton Dickinson (BDX) United States $68.110B 19.27
West Pharmaceutical Services (WST) United States $26.529B 47.54
Cardinal Health (CAH) United States $24.242B 13.86
Align Technology (ALGN) United States $20.454B 39.49
Cooper (COO) United States $18.834B 28.50
Labcorp (LH) United States $17.507B 15.07
Henry Schein (HSIC) United States $9.419B 16.70
DENTSPLY SIRONA (XRAY) United States $5.791B 14.99
Merit Medical Systems (MMSI) United States $4.697B 25.74
Patterson (PDCO) United States $2.267B 10.86
CONMED (CNMD) United States $2.192B 19.88
STAAR Surgical (STAA) United States $2.081B 79.91
Atrion (ATRI) United States $0.784B 41.86
Lifevantage (LFVN) United States $0.085B 10.98
Pro-Dex (PDEX) United States $0.064B 32.09
Biolase (BIOL) United States $0.006B 0.00